SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001640334-22-002578
Filing Date
2022-12-07
Accepted
2022-12-07 16:15:48
Documents
15
Period of Report
2022-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A yubo_8ka.htm   iXBRL 8-K/A 26120
2 SECURITIES PURCHASE AGREEMENT yubo_ex102.htm EX-10.2 14141
  Complete submission text file 0001640334-22-002578.txt   169633

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA yubo-20220902.xsd EX-101.SCH 5720
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE yubo-20220902_lab.xml EX-101.LAB 14709
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE yubo-20220902_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE yubo-20220902_pre.xml EX-101.PRE 9296
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE yubo-20220902_def.xml EX-101.DEF 2099
9 EXTRACTED XBRL INSTANCE DOCUMENT yubo_8ka_htm.xml XML 4594
Mailing Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000
Business Address ROOM 105, BUILDING 5, 31 XISHIKU AVENUE BEIJING F4 00000 86 (010) 6615-5141
Yubo International Biotech Ltd (Filer) CIK: 0000895464 (see all company filings)

IRS No.: 113074326 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-21320 | Film No.: 221450375
SIC: 3845 Electromedical & Electrotherapeutic Apparatus